These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2548904

  • 1. Lipoprotein receptors and atherosclerosis.
    Kostner GM.
    Biochem Soc Trans; 1989 Aug; 17(4):639-41. PubMed ID: 2548904
    [Abstract] [Full Text] [Related]

  • 2. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
    Auger A, Truong TQ, Rhainds D, Lapointe J, Letarte F, Brissette L.
    Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
    [Abstract] [Full Text] [Related]

  • 3. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028
    [Abstract] [Full Text] [Related]

  • 4. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
    Fong BS, Rodrigues PO, Salter AM, Yip BP, Despres JP, Angel A, Gregg RE.
    J Clin Invest; 1985 Jun 24; 75(6):1804-12. PubMed ID: 2989332
    [Abstract] [Full Text] [Related]

  • 5. Diabetes and lipoprotein receptors.
    Kraemer FB.
    Diabetes Metab Rev; 1987 Jul 24; 3(3):591-618. PubMed ID: 3038488
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of a human hepatic receptor for high density lipoproteins.
    Hoeg JM, Demosky SJ, Edge SB, Gregg RE, Osborne JC, Brewer HB.
    Arteriosclerosis; 1985 Jul 24; 5(3):228-37. PubMed ID: 2986587
    [Abstract] [Full Text] [Related]

  • 7. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
    Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP.
    Arterioscler Thromb; 1994 Nov 24; 14(11):1767-74. PubMed ID: 7947602
    [Abstract] [Full Text] [Related]

  • 8. The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis.
    Knecht TP, Glass CK.
    Adv Genet; 1995 Nov 24; 32():141-98. PubMed ID: 7741021
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat.
    Landschulz KT, Pathak RK, Rigotti A, Krieger M, Hobbs HH.
    J Clin Invest; 1996 Aug 15; 98(4):984-95. PubMed ID: 8770871
    [Abstract] [Full Text] [Related]

  • 10. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE, van Gent T, van Tol A.
    Biochim Biophys Acta; 1989 Mar 14; 1002(1):93-100. PubMed ID: 2493808
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF.
    Circulation; 2003 Nov 04; 108(18):2258-63. PubMed ID: 14581413
    [Abstract] [Full Text] [Related]

  • 12. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM, Sullivan MA, Kim SK, Ambroziak P, Chu A, Wilson MD, Hellerstein MK, Rudel LL, Walzem RL, Young SG.
    J Clin Invest; 2000 Dec 04; 106(12):1501-10. PubMed ID: 11120757
    [Abstract] [Full Text] [Related]

  • 13. ApoB-containing lipoproteins in apoE-deficient mice are not metabolized by the class B scavenger receptor BI.
    Webb NR, de Beer MC, de Beer FC, van der Westhuyzen DR.
    J Lipid Res; 2004 Feb 04; 45(2):272-80. PubMed ID: 14563829
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.
    Arterioscler Thromb Vasc Biol; 2005 Apr 04; 25(4):785-90. PubMed ID: 15692094
    [Abstract] [Full Text] [Related]

  • 17. Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates.
    Laffont I, Shuvaev VV, Briand O, Lestavel S, Barbier A, Taniguchi N, Fruchart JC, Clavey V, Siest G.
    Biochim Biophys Acta; 2002 Jun 13; 1583(1):99-107. PubMed ID: 12069854
    [Abstract] [Full Text] [Related]

  • 18. Receptors and lipid transfer proteins in HDL metabolism.
    Silver DL, Jiang XC, Arai T, Bruce C, Tall AR.
    Ann N Y Acad Sci; 2000 May 13; 902():103-11; discussion 111-2. PubMed ID: 10865830
    [Abstract] [Full Text] [Related]

  • 19. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
    Rhainds D, Brodeur M, Lapointe J, Charpentier D, Falstrault L, Brissette L.
    Biochemistry; 2003 Jun 24; 42(24):7527-38. PubMed ID: 12809509
    [Abstract] [Full Text] [Related]

  • 20. Expression of lipoprotein receptors and related molecules in atherosclerotic lesions.
    Ylä-Herttuala S.
    Curr Opin Lipidol; 1996 Oct 24; 7(5):292-7. PubMed ID: 8937519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.